z-logo
Premium
Methyl p‐hydroxybenzoate (E‐218) a preservative for drugs and food is an activator of the ryanodine receptor Ca 2+ release channel
Author(s) -
Cavagna Dario,
Zorzato Francesco,
Babini Elena,
Prestipino Gianfranco,
Treves Susan
Publication year - 2000
Publication title -
british journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.432
H-Index - 211
eISSN - 1476-5381
pISSN - 0007-1188
DOI - 10.1038/sj.bjp.0703571
Subject(s) - haloperidol , activator (genetics) , ryanodine receptor , chemistry , preservative , calcium , skeletal muscle , pharmacology , endoplasmic reticulum , medicine , biochemistry , receptor , food science , dopamine , organic chemistry
Haloperidol is a drug used in the management of several psychotic disorders and its use has been linked to Neuroleptic Malignant Syndrome. In the present study we have investigated the effect of a commercial preparation of haloperidol, Serenase, on skeletal muscle sarcoplasmic reticulum. Addition of Serenase to isolated terminal cisternae caused a rapid release of calcium. We tested whether the active Ca 2+ ‐releasing substance was haloperidol or another compound present in the preparation. Our results show that methyl p‐hydroxybenzoate, one of the preservatives and a commonly used anti‐microbial agent (E‐218) is an activator of Ca 2+ release (E.C.50=2.0 m M ), mediated by a ruthenium red‐sensitive Ca 2+ release channel present in skeletal muscle terminal cisternae.British Journal of Pharmacology (2000) 131 , 335–341; doi: 10.1038/sj.bjp.0703571

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom